Belimumab With Rituximab for the Treatment of Primary Membranous Nephropathy.
Year: 2026
Type: article
Study design: Clinical Trial
Abstract: B cell depletion with rituximab (RTX) leads to complete or partial remission (CR or PR) in approximately 60% of patients with primary membranous nephropathy (PMN). Adding belimumab (BEL) to RTX may result in greater depletion of memory B cells, limit the reemergence of autoreactive B cells, and improve clinical responses.REBOOT Part A (NCT03949855) is a single arm, open-label, pharmacokinetic study where all participants had proteinuria (≥ 4 g/d) and detectable serum anti-phospholipase A2 receptor (anti-PLA2R) antibodies. Participants received BEL 200 mg subcutaneously weekly for 52 weeks and RTX 1000 mg intravenously at weeks 4 and 6. Assessments included BEL exposure at week 4 and CR or PR at week 104.A total of 17 participants started BEL. BEL exposure was not significantly reduced in those with high proteinuria (≥8 g/day) at week 4. Among all treated participants, 10/17 (59%) achieved CR or PR at week 104, whereas in per protocol analyses, 10/11 (91%) achieved CR or PR at week 104. All participants in per protocol analyses had normal serum albumin and undetectable serum anti-PLA2R by week 104. Circulating memory B cells increased before RTX and were depleted by RTX. B cell reconstitution occurred after week 52 with primarily naive and transitional B cells. BEL with RTX was well-tolerated, with 1 participant discontinuing BEL due to infection.In this study, a high proportion of participants receiving BEL with RTX achieved CR or PR. Therefore, a multitargeted approach to B cell depletion may improve immunologic and clinical outcomes in PMN and is being studied in a larger, randomized, placebo-controlled clinical trial.
Source: UNC Libraries
DOI: 10.17615/dzqj-3v97
Authors: Gao, Wendy, Tuttle, Katherine R, Coppock, Gaia, Aslam, Nabeel, Tosta, Patricia, Sherman, Matthew A, Waldman, Meryl, Nachman, Patrick H, Derebail, Vimal K, Ayoub, Isabelle, Rizk, Dana V, Cooney, Laura A, Chung, Sharon A, Barry, William T, Kamal, Fahmeedah, Adler, Sharon, Bomback, Andrew S, Stelzig, Lia
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7235406335
